Portal Biotechnologies
Arlington, US · Founded 2022 · Delaware corporation · 5 known investors
Find your way into Portal Biotechnologies
1,190 people in our graph share verified history with the Portal Biotechnologies team — schools, employers, funds. One of them is your warm intro.
Paul Kwanunlockedknows Armon Sharei · together at Stanford University (overlapped)
×6knows the team · via Stanford University
knows the team · via Harvard Medical School
×3knows the team · via Massachusetts Institute of Technology
knows the team · via Pear VC
Founders & leadership
Portal Biotechnologies was founded in 2022 by Armon Sharei.
AS
Armon ShareiinFounderArmon Sharei holds a PhD in chemical engineering from MIT and founded and led SQZ Biotech for 10 years before it went public; he now serves as Chief Executive Officer and Founder of Portal Biotechnologies, a cell engineering platform company, and has authored over 20 peer-reviewed publications.
Investors · 5
Funding
SEC filings, press & company announcements$20.7M disclosed across 2 of 3 rounds · 2024–2026
- Undisclosed amountPre-SeedMar 2024Source ↗
▶$9MraisedMay 2026 · 12 investors · BiotechnologyRule 506(b)
▶$9MraisedMay 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Armon ShareiExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $9M
- Minimum investment
- $30K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$11.7MraisedMay 2026 · 43 investors · BiotechnologyRule 506(b)
▶$11.7MraisedMay 2026 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Armon ShareiExecutive Officer, Director
- Alec BarlcayExecutive Officer, Director
- Offering amount
- $11.9M
- Amount sold
- $11.7M
- Minimum investment
- $10K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Portal Biotechnologies Raises $9M in Fundingfinsmes.com · Jun 2026
Portal Biotechnologies Raises $9 Million to Scale Cell Engineering Platform | citybizcitybiz.co · Jun 2026Frequently asked questions
- Who founded Portal Biotechnologies?
- Portal Biotechnologies was founded by Armon Sharei in 2022.
- Who are Portal Biotechnologies's investors?
- Portal Biotechnologies's investors include IA Ventures, IKJ Capital, NFX, Pear VC, TechU Ventures.
- How much funding has Portal Biotechnologies raised?
- Portal Biotechnologies has disclosed $20.7M raised across 2 of its 3 known rounds.
- Where is Portal Biotechnologies headquartered?
- Portal Biotechnologies is headquartered in Arlington, US.